Invesco
MACK

Invesco’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Invesco’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-277,124
Closed -$4.09M – 4039
2024
Q1 		$4.09M Buy
277,124
+265,058
+2,197% +$3.72M ﹤0.01% 2353
2023
Q4 		$162K Buy
+12,066
New +$152K ﹤0.01% 3603
2023
Q2 		– Sell
-210,507
Closed -$2.59M – 4046
2023
Q1 		$2.59M Buy
+210,507
New +$2.47M ﹤0.01% 2535
2020
Q1 		– Sell
-50,683
Closed -$160K – 3822
2019
Q4 		$160K Sell
50,683
-3,344
-6% -$13.4K ﹤0.01% 3559
2019
Q3 		$243K Sell
54,027
-17,326
-24% -$86.6K ﹤0.01% 3495
2019
Q2 		$340K Sell
71,353
-2,460
-3% -$11.7K ﹤0.01% 3461
2019
Q1 		$404K Buy
+73,813
New +$339K ﹤0.01% 3385
2015
Q3 		– Sell
-30,861
Closed -$3M – 4188
2015
Q2 		$3M Sell
30,861
-19,281
-38% -$1.83M ﹤0.01% 2358
2015
Q1 		$4.69M Buy
50,142
+8,845
+21% +$753K ﹤0.01% 2014
2014
Q4 		$3.67M Buy
41,297
+15,696
+61% +$1.14M ﹤0.01% 2115
2014
Q3 		$1.77M Sell
25,601
-24,252
-49% -$1.3M ﹤0.01% 2607
2014
Q2 		$2.86M Buy
+49,853
New +$2.53M ﹤0.01% 2355
2014
Q1 		– Sell
-763
Closed -$32K – 4391
2013
Q4 		$32K Hold
763
– – ﹤0.01% 4127
2013
Q3 		$23K Sell
763
-7,095
-90% -$248K ﹤0.01% 4147
2013
Q2 		$416K Buy
+7,858
New +$344K ﹤0.01% 3364

Other funds holding MACK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Invesco's MACK Position: Q2 2024 in Review

Invesco sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 277,124 shares — an estimated $4.09M sold.

Invesco first reported a position in MACK in Q2 2013 and held it in 15 quarters. The position peaked at $4.69M in Q1 2015. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

  • Invesco reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
  • Invesco sold 277,124 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $4.09M.
  • Invesco first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 15 quarters.
  • Invesco's Merrimack Pharmaceuticals, Inc. position peaked at $4.69M in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.